Clinical Trial Update: Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients [Phase 2]

View source ↗

Summary

Phase II Japanese study of SB-497115-GR in chronic hepatitis C has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SB-497115-GR

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2015-02-23